Back
Brainstorm Cell Therapeutics Vs. Criteo SA Industry Stock Comparison
Sell
7
BCLI
Brainstorm Cell Therapeutics
Last Price:
1.87
Seasonality Move:
2.27%
Sell
1
CRTO
Criteo SA
Last Price:
33.70
Seasonality Move:
3.01%
Sell
7
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
- The current Brainstorm Cell Therapeutics [BCLI] share price is $1.87. The Score for BCLI is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
- BCLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
1
Criteo SA (CRTO)
is a Sell
Is Criteo SA a Buy, Sell or Hold?
- The current Criteo SA [CRTO] share price is $33.70. The Score for CRTO is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- CRTO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
BCLI Stock Price Chart
What is Brainstorm Cell Therapeutics's stock price today?
-
The Brainstorm Cell Therapeutics share price today is $1.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.
CRTO Stock Price Chart
BCLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.39 | Sell |
Relative Strength Index (14 RSI): | 30.53 | Sell |
Chaikin Money Flow: | -6697 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.82 - 2.88) | Sell |
Bollinger Bands (100): | (2.96 - 5.76) | Sell |
CRTO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.22 | Sell |
Relative Strength Index (14 RSI): | 27.9 | Sell |
Chaikin Money Flow: | -369188 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.98 - 42.2) | Sell |
Bollinger Bands (100): | (38.17 - 45.99) | Sell |
BCLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.97 | Sell |
20-day SMA: | 2.11 | Sell |
50-day SMA: | 3.3 | Sell |
200-day SMA: | 5.56 | Sell |
8-day EMA: | 1.99 | Sell |
20-day EMA: | 2.27 | Sell |
50-day EMA: | 3.11 | Sell |
200-day EMA: | 6.38 | Sell |
CRTO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.37 | Sell |
20-day SMA: | 40.15 | Sell |
50-day SMA: | 42.45 | Sell |
200-day SMA: | 37.92 | Sell |
8-day EMA: | 38.4 | Sell |
20-day EMA: | 39.95 | Sell |
50-day EMA: | 41.35 | Sell |
200-day EMA: | 38.51 | Sell |
Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.79 per share, and an increase next year of $0.67 per share.
Criteo SA Earnings Growth & CRTO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.47 per share, and an increase next year of $0.14 per share.
Brainstorm Cell Therapeutics Technical Analysis
Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Criteo SA Technical Analysis
Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |